Literature DB >> 33015782

LncRNA FAM83A-AS1 aggravates the malignant development of esophageal cancer by binding to miR-495-3p.

G-M Huang1, H-L Zang, Y-X Geng, Y-H Li.   

Abstract

OBJECTIVE: It is of significance to screen out differentially expressed long non-coding RNAs (lncRNAs) that can be utilized as tumor biomarkers in esophageal cancer. This study aims to uncover the effect of lncRNA FAM83A-AS1 on regulating migratory potential in esophageal cancer and the underlying mechanism. PATIENTS AND METHODS: Tumor tissues and adjacent normal ones were collected from 62 esophageal cancer patients for detecting FAM83A-AS1 levels. Correlations of FAM83A-AS1 with clinical indexes and overall survival of esophageal cancer patients were analyzed. Thereafter, regulatory effects of FAM83A-AS1 on migratory potential in OE19 and OE33 cells were examined by transwell and wound healing assay. Then, the target genes of FAM83A-AS1 were predicted and functionally analyzed, and a protein interaction network was constructed. Finally, the mechanism of FAM83A-AS1 in regulating the downstream gene miR-495-3p was analyzed through Luciferase assay and rescue experiments.
RESULTS: It was found that FAM83A-AS1 was upregulated in esophageal cancer tissues and cell lines. Higher rates of lymphatic and distant metastasis and worse survival were observed in esophageal cancer patients expressing higher level of FAM83A-AS1. Besides, the knockdown of FAM83A-AS1 suppressed migratory potential in OE19 cells, while the overexpression of FAM83A-AS1 yielded the opposite trend in OE33 cells. Moreover, miR-495-3p was indicated to be the target gene binding FAM83A-AS1, and it was lowly expressed in esophageal cancer and negatively regulated by FAM83A-AS1. Furthermore, the overexpression of miR-495-3p partially abolished the regulatory effect of FAM83A-AS1 on migratory potential in esophageal cancer.
CONCLUSIONS: FAM83A-AS1 is upregulated in esophageal cancer, and it stimulates migratory potential in esophageal cancer by negatively regulating miR-495-3p.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33015782     DOI: 10.26355/eurrev_202009_23024

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  8 in total

1.  FAM83A antisense RNA 1 (FAM83A-AS1) silencing impairs cell proliferation and induces autophagy via MET-AMPKɑ signaling in lung adenocarcinoma.

Authors:  Huijie Zhao; Yinghan Wang; Xing Wu; Xaofei Zeng; Baoyue Lin; Shengmin Hu; Shenglin Zhang; Yu Li; Zhiqing Zhou; Yujie Zhou; Changzheng Du; David G Beer; Shengbin Bai; Guoan Chen
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

2.  lncRNA RP11-10A14.5: a potential prognosis biomarker for LUAD through regulation on proliferation and metastasis.

Authors:  Zhijie Lin; Fenglan Feng; Jiaming Liang; Haikang Zeng; Jin Li
Journal:  Discov Oncol       Date:  2022-05-16

3.  FAM83A and FAM83A-AS1 both play oncogenic roles in lung adenocarcinoma.

Authors:  Gaoming Wang; Xiaokun Li; Yu Yao; Zhisheng Jiang; Hai Zhou; Kai Xie; Jing Luo; Yi Shen
Journal:  Oncol Lett       Date:  2021-02-17       Impact factor: 2.967

4.  Identification of the Prognostic Significance of Somatic Mutation-Derived LncRNA Signatures of Genomic Instability in Lung Adenocarcinoma.

Authors:  Wei Geng; Zhilei Lv; Jinshuo Fan; Juanjuan Xu; Kaimin Mao; Zhengrong Yin; Wanlu Qing; Yang Jin
Journal:  Front Cell Dev Biol       Date:  2021-03-29

5.  Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression.

Authors:  Hongyu Huang; Chuyi Yang; Qichen Zhang; Ting Zhuo; Xiaohong Li; Nijiao Li; Lu Zhu; Chenyang Luo; Jinyan Gan; Yanbin Wu
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

6.  miR-495-3p depresses cell proliferation and migration by downregulating HMGB1 in colorectal cancer.

Authors:  Jie Ling Zhang; Hui Fen Zheng; Kai Li; Yi Ping Zhu
Journal:  World J Surg Oncol       Date:  2022-03-30       Impact factor: 2.754

7.  A two-phase comprehensive NSCLC prognostic study identifies lncRNAs with significant main effect and interaction.

Authors:  Jing Zhu; Jinxing Guan; Xinyu Ji; Yunjie Song; Xiaoshuang Xu; Qianqian Wang; Quanan Zhang; Renhua Guo; Rui Wang; Ruyang Zhang
Journal:  Mol Genet Genomics       Date:  2022-02-26       Impact factor: 3.291

8.  Necroptosis-related lncRNA in lung adenocarcinoma: A comprehensive analysis based on a prognosis model and a competing endogenous RNA network.

Authors:  Fuling Mao; Zihao Li; Yongwen Li; Hua Huang; Zijian Shi; Xuanguang Li; Di Wu; Hongyu Liu; Jun Chen
Journal:  Front Genet       Date:  2022-09-08       Impact factor: 4.772

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.